US Lawyer Database

Section 414.414 – Use and disclosure of confidential information.

(1) Information collected under ORS 414.351 to 414.414 that identifies an individual is confidential and may not be disclosed by the Pharmacy and Therapeutics Committee, the retrospective program or the Oregon Health Authority to any person other than a health care provider appearing on a recipient’s medication profile. (2) The staff of the committee may […]

Section 414.332 – Policy for Practitioner-Managed Prescription Drug Plan.

It is the policy of the State of Oregon that a Practitioner-Managed Prescription Drug Plan will ensure that: (1) Oregonians have access to the most effective prescription drugs appropriate for their clinical conditions; (2) Decisions concerning the clinical effectiveness of prescription drugs are made by licensed health practitioners, are informed by the latest peer-reviewed research […]

Section 414.420

[Formerly 414.026; 2009 c.595 §309a; renumbered 411.443 in 2009]

Section 414.424

[2005 c.494 §2; 2007 c.70 §193; 2009 c.414 §1; renumbered 411.439 in 2009]

Section 414.351 – Definitions for ORS 414.351 to 414.414.

As used in ORS 414.351 to 414.414: (1) “Compendia” means those resources widely accepted by the medical profession in the efficacious use of drugs, including the following sources: (a) The American Hospital Formulary Service drug information. (b) The United States Pharmacopeia drug information. (c) The American Medical Association drug evaluations. (d) Peer-reviewed medical literature. (e) […]

Section 414.353 – Committee established; membership.

(1) There is created an 11-member Pharmacy and Therapeutics Committee responsible for advising the Oregon Health Authority on the implementation of the retrospective and prospective programs and on the Practitioner-Managed Prescription Drug Plan. (2) The Director of the Oregon Health Authority shall appoint the members of the committee, who shall serve at the pleasure of […]

Section 414.354 – Meetings; advisory committees; public notice and testimony.

(1) Except as provided in ORS 414.356, the Pharmacy and Therapeutics Committee shall operate in accordance with ORS chapter 192. The committee shall annually elect a chairperson from the members of the committee. (2) A committee member is not entitled to compensation but is entitled to reimbursement for actual and necessary travel expenses incurred in […]